Companies looking to differentiate themselves in the marketplace often make bold moves into areas that they feel will give them a leg up compared to competitors. But sometimes who they buy can lead to some headscratching Such is the case with Alira Health, a health consulting firm serving life science companies, which added a crowdfunding […]

Amid the overdose crisis, the bulk of national attention lies on opioids like fentanyl. This has seen the opioid-overdose reversal drug naloxone become a household name, and become more widely available. However, as it stands, there aren’t any “overdose” reversal drugs that work for other classifications of drugs, like stimulants. To address this, the company […]

Wednesday offers a rare opportunity for Amylyx Pharmaceuticals, which will go before the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee in a second attempt to win recommendation for its amyotrophic lateral sclerosis (ALS) drug, AMX0035. The FDA provided briefing documents Friday, and despite the unusual second adcomm, it does not appear to be convinced. To be […]